In re Elysium Health-Chromadex Litig.

McMahon, C.J.:

On September 27, 2017, Plaintiff Elysium Health, Inc. ("Elysium") filed a complaint ("Complaint") against Defendant *333Chromadex, Inc. ("CMDX"), alleging violations of § 43(a) of the Lanham Act, as well as state law claims of trade libel, deceptive business practices under New York General Business Law § 349, and tortious interference with prospective economic relations.

Presently before the Court is CMDX's Motion for Summary Judgment based on a claim of immunity under the Noerr - Pennington doctrine.

For the reasons that follow, CMDX's Motion is GRANTED.

I. Background

The Court…